Premphase allegedly linked to Heart Attack and Cancer
Reports of Hematological and Neurological Side EffectsPremphase is a hormone replacement therapy (HRT) prescribed for menopause symptoms. Premphase (conjugated estrogens and medroxyprogesterone acetate) has been linked to the following side effects: coronary heart disease, stroke, blood clots, dementia, Alzheimer's disease, pulmonary embolisms, lupus and breast cancer.
The "black box" warning issued by Wyeth Pharmaceuticals states, "The use of PREMPHASE may increase your chance of having a heart attack, a stroke, blood clots, a pulmonary embolus (a blood clot formed in the legs or pelvis that breaks off and travels to the lungs), retinal thrombosis (a clot in a blood vessel of the eye), or other blood clotting problems. Any of these conditions may cause death or serious long-term disability. These conditions have been seen in healthy, postmenopausal women, as well as in women with a history of heart disease."
Possible Premphase heart attack or cancer lawsuitIf you or a family member have used Premphase and have suffered heart attack, breast cancer, or blood clots, you may be entitled to compensation.
Register your Premphase ComplaintIf you feel you qualify for damages or remedies that might be awarded in a possible Premphase heart attack or breast cancer lawsuit, please click the link below to submit your complaint.
Published on Nov-24-04